Package 65862-057-11

{"route": ["ORAL"], "spl_id": "fd37e474-7411-4466-bf46-36fc74ef6684", "openfda": {"unii": ["B7XF2TD73C"], "rxcui": ["311943"], "spl_set_id": ["8dfe86aa-ea5d-48d2-94a8-1a5506055d70"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (65862-057-11)", "package_ndc": "65862-057-11", "marketing_start_date": "20120522"}, {"sample": false, "description": "240 mL in 1 BOTTLE (65862-057-24)", "package_ndc": "65862-057-24", "marketing_start_date": "20120522"}], "brand_name": "Nevirapine", "product_id": "65862-057_fd37e474-7411-4466-bf46-36fc74ef6684", "dosage_form": "SUSPENSION", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65862-057", "generic_name": "Nevirapine", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE HEMIHYDRATE", "strength": "50 mg/5mL"}], "application_number": "ANDA077702", "marketing_category": "ANDA", "marketing_start_date": "20120522", "listing_expiration_date": "20261231"}